BMS Voluntarily Recalls Rheumatoid Arthritis Drug In Japan
This article was originally published in PharmAsia News
Executive Summary
Bristol-Myers Squibb voluntarily recalled rheumatoid arthritis drug Kenacort-A (triamcinolone) 50gm/5ml and 40mg/1ml injections in Japan, due to reported swelling and aches in administrated areas. Although such symptoms are listed in the package insert, the company received multiple reports of such cases in Japan and decided to recall the products. BMS also halted shipping the products pending investigation results. The company estimated around 10,000 units stocked in Japanese medical facilities nationwide. (Click here for more - Japanese language